Retrophin Secures $24,916,307 New Round

  • Feed Type
  • Date
    10/8/2013
  • Company Name
    Retrophin
  • Mailing Address
    777 Third Avenue 22nd Floor New York, NY 10017
  • Company Description
    Retrophin, LLC is a privately-held New York-based, biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases.
  • Website
    http://www.retrophin.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $24,916,307
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy